Ianalumab (VAY-736) is a decarboxylated humanized antibody against BAFF-R that inhibits the interaction between BAFF and BAFF-R, blocking BAFF-mediated apoptosis protection. Ianalumab exhibits antibody-dependent cytotoxicity (ADCC) and activates effector cells via the immune receptor tyrosine activation motif (ITAM).
Purity:
>95%
CAS Number:
[1929549-92-7]
Target:
TNF|||Others
* VAT and and shipping costs not included. Errors and price changes excepted